Lol. Man who says phase iv trials would be needed before going to market says others are ignorant of the approval process.
Ann: Media release - First stroke patient with afamelanotide, page-13
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.57 |
Change
-0.010(0.07%) |
Mkt cap ! $730.1M | |||
| Open | High | Low | Value | Volume |
| $14.61 | $14.99 | $14.40 | $448.8K | 30.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 264 | $14.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.60 | 76 | 2 |
View Market Depth
| Last trade - 10.32am 10/07/2024 (20 minute delay) ? |
| CUV (ASX) Chart |